Incremental value of left atrial strain to predict atrial fibrillation recurrence after cryoballoon ablation.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 03 08 2021
accepted: 01 11 2021
entrez: 19 11 2021
pubmed: 20 11 2021
medline: 5 1 2022
Statut: epublish

Résumé

Atrial fibrillation (AF) recurrence occurs in approximately 25% of the patients undergoing cryoballoon ablation (CBA), leading to repeated ablations and complications. Left atrial (LA) dilation has been proposed as a predictor of AF recurrence. However, LA strain is a surrogate marker of LA mechanical dysfunction, which might appear before the enlargement of the LA. The purpose of this study was to evaluate the additional predictive value of LA function assessed using strain echocardiography for AF recurrence after CBA. 172 consecutive patients (62.2 ± 12.2 years, 61% male) were prospectively analyzed. Echocardiography was performed before CBA. Blanking period was defined as the first three months post-ablation. The primary endpoint was AF recurrence after the blanking period. 50 (29%) patients had AF recurrence. In the overall study population, peak atrial longitudinal strain (PALS) ≤ 17% had the highest incremental predictive value for AF recurrence (HR = 9.45, 95%CI: 3.17-28.13, p < 0.001). In patients with non-dilated LA, PALS≤17% remained an independent predictor of AF recurrence (HR = 5.39, 95%CI: 1.66-17.52, p = 0.005). This study showed that LA function assessed by PALS provided an additional predictive value for AF recurrence after CBA, over LA enlargement. In patients with non-dilated LA, PALS also predicted AF recurrence. These findings emphasize the added value of LA strain, suggesting that it should be implemented in the systematic evaluation of AF patients before CBA.

Identifiants

pubmed: 34797844
doi: 10.1371/journal.pone.0259999
pii: PONE-D-21-25110
pmc: PMC8604362
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0259999

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am Heart J. 2021 Jan;231:82-92
pubmed: 33098808
Pacing Clin Electrophysiol. 2021 May;44(5):883-894
pubmed: 33813746
Pacing Clin Electrophysiol. 2008 Dec;31(12):1606-11
pubmed: 19067814
Eur Heart J. 2016 Oct 07;37(38):2858-2865
pubmed: 27381589
Europace. 2019 May 1;21(5):732-737
pubmed: 30689857
Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):591-600
pubmed: 29596561
J Atr Fibrillation. 2013 Dec 31;6(4):986
pubmed: 28496919
Int J Cardiovasc Imaging. 2020 Jul;36(7):1293-1309
pubmed: 32248332
Cardiol Ther. 2020 Jun;9(1):45-58
pubmed: 31898209
PLoS One. 2020 Aug 21;15(8):e0238002
pubmed: 32822402
Europace. 2016 Jul;18(7):987-93
pubmed: 26705562
Clin Cardiol. 2017 Jun;40(6):413-418
pubmed: 28273368
Eur Heart J Cardiovasc Imaging. 2019 Jul 1;20(7):804-815
pubmed: 30541074
Echocardiography. 2016 May;33(5):724-33
pubmed: 26857344
Open Heart. 2017 Apr 28;4(1):e000572
pubmed: 28674624
Europace. 2020 Dec 23;22(12):1798-1804
pubmed: 33006599
J Am Coll Cardiol. 2014 Feb 18;63(6):493-505
pubmed: 24291276
J Am Soc Echocardiogr. 2011 Aug;24(8):898-908
pubmed: 21665431
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
J Am Coll Cardiol. 2020 Jun 30;75(25):3105-3118
pubmed: 32586583
Cardiovasc Ultrasound. 2018 Sep 25;16(1):19
pubmed: 30249263
J Interv Card Electrophysiol. 2020 Apr;57(3):425-434
pubmed: 31016428
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4997-5007
pubmed: 32432763
J Am Coll Cardiol. 2019 Apr 23;73(15):1961-1977
pubmed: 31000000
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
J Interv Card Electrophysiol. 2020 Jun;58(1):51-59
pubmed: 31183664
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360
pubmed: 27422899
Am J Cardiol. 2013 Apr 1;111(7):1002-11
pubmed: 23337834
Diagnostics (Basel). 2020 Nov 13;10(11):
pubmed: 33202837
J Interv Card Electrophysiol. 2016 Aug;46(2):145-51
pubmed: 26825976

Auteurs

Andreea Motoc (A)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Maria-Luiza Luchian (ML)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Esther Scheirlynck (E)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Bram Roosens (B)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Hadischat Chameleva (H)

Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.

Maxim Gevers (M)

Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.

Xavier Galloo (X)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Berlinde von Kemp (B)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Robbert Ramak (R)

Heart Rhythm Management Centre, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Juan Sieira (J)

Heart Rhythm Management Centre, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Carlo de Asmundis (C)

Heart Rhythm Management Centre, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Gian-Battista Chierchia (GB)

Heart Rhythm Management Centre, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Julien Magne (J)

Service Cardiologie, CHU Limoges, Hôpital Dupuytren, Limoges, France.
16 INSERM 1094, Faculté de Médecine de Limoges, Limoges, France.

Caroline Weytjens (C)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Steven Droogmans (S)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Bernard Cosyns (B)

Department of Cardiology, (Centrum voor Hart- en Vaatziekten), Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH